PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 62 filers reported holding PLIANT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $14,269,000 | -52.5% | 490,000 | -35.9% | 0.06% | -61.1% |
| Q1 2021 | $30,058,000 | +73.1% | 764,262 | 0.0% | 0.15% | +43.3% |
| Q4 2020 | $17,364,000 | +0.4% | 764,262 | 0.0% | 0.10% | -13.3% |
| Q3 2020 | $17,288,000 | -37.4% | 764,262 | -10.2% | 0.12% | -45.7% |
| Q2 2020 | $27,617,000 | – | 850,801 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
| CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
| TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
| Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
| Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
| Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
| HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
| Grace Capital | 48,058 | $808,000 | 0.50% |
| Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
| Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |